Infinity Pharmaceuticals CEO Discusses Cancer Drugs

Infinity Pharmaceuticals CEO Discusses Cancer Drugs Play

April 5 (Bloomberg) -- Adelene Perkins, chief executive officer Infinity Pharmaceuticals Inc., and Simos Simeonidis, an analyst with Cowen & Co., talk about the outlook for targeted cancer drugs. They speak with Pimm Fox on Bloomberg Television's "Taking Stock." Bloomberg's Meg Tirrell also speaks. (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus